At a glance
ClinicalIndex Comparison RecordN/ACompleted· 25 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Geometric Reproducibility of the Lumpectomy Cavity Using a Breast Cup Immobilization Device II
In Brief
An observational study for Breast Cancer. Completed, enrolled 25 participants across 1 site.
Detailed Summary
The study is designed to assess the accuracy of patient breast reproducibly using the revised BCID. This study would provide data for target verification and quality assurance to eventually allow treatment of breast cancer patients for either a TBB or accelerated partial breast irradiation. The BCID is a low-risk device similar to immobilization devices used routinely in radiotherapy for other disease sites.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2012
First PostedOct 2012
Primary CompletionMar 2016
TodayJul 2026
First PostedOct 11, 2012
Enrollment StartOct 1, 2012
Primary CompletionMar 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 13.7 years ago